Bristol-Myers Squibb Live Stock Price Today, Share Analysis and Chart

Name: Bristol-Myers Squibb Co.: Is Infosys Ltd. worth buying?
Item: Bristol-Myers Squibb Co.
Rating: 2.673958375
Author: Trendlyne DVM scores

Mid-range Performer

about

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol deriv...

54.11 -0.53 (-0.97%)

27.26% Gain from 52W Low

9.2M

XNYS Volume

XNYS 29 Dec, 2025 4:30 PM (EST)

Medium Financial Strength

50.0 / 100

Affordable Valuation

58.2 / 100

Technically Neutral

55.8 / 100

Mid-range Performer These stocks have affordable valuations, but mid range financials and momentum View Similar Embed DVM

1Yr Price target upside is 2%

23 analysts

Bristol-Myers Squibb Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bristol-Myers Squibb Live Stock Price Today, Share Analysis and Chart

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol deriv...

27.26% Gain from 52W Low

SWOT Analysis

Bristol-Myers Squibb Live Price Chart